Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment].
Pommier P, Morelle M, Perrier L, de Crevoisier R, Laplanche A, Dudouet P, Mahé MA, Chauvet B, Nguyen TD, Créhange G, Zawadi A, Chapet O, Latorzeff I, Bossi A, Beckendorf V, Touboul E, Muracciole X, Bachaud JM, Supiot S, Lagrange JL. Pommier P, et al. Among authors: laplanche a. Cancer Radiother. 2012 Sep;16(5-6):444-51. doi: 10.1016/j.canrad.2012.07.178. Epub 2012 Aug 27. Cancer Radiother. 2012. PMID: 22951488 Clinical Trial. French.
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.
de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL. de Crevoisier R, et al. Among authors: laplanche a. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31. Int J Radiat Oncol Biol Phys. 2018. PMID: 30071296 Clinical Trial.
Cost of prostate image-guided radiation therapy: results of a randomized trial.
Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, de Crevoisier R. Perrier L, et al. Among authors: laplanche a. Radiother Oncol. 2013 Jan;106(1):50-8. doi: 10.1016/j.radonc.2012.11.011. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333022 Free article. Clinical Trial.
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
Theodore C, Bidault F, Bouvet-Forteau N, Abdelatif M, Fizazi K, di Palma M, Wibault P, de Crevoisier R, Laplanche A. Theodore C, et al. Among authors: laplanche a. Ann Oncol. 2006 Jun;17(6):990-4. doi: 10.1093/annonc/mdl057. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600984 Free article. Clinical Trial.
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer.
Rajpar S, Massard C, Laplanche A, Tournay E, Gross-Goupil M, Loriot Y, Di Palma M, Bossi A, Escudier B, Chauchereau A, Fizazi K. Rajpar S, et al. Among authors: laplanche a. Ann Oncol. 2010 Sep;21(9):1864-1869. doi: 10.1093/annonc/mdq037. Epub 2010 Feb 24. Ann Oncol. 2010. PMID: 20181574 Free article.
[Role and perspectives of sentinel node biopsy in head and neck tumors].
Mamelle G, Temam S, Casiraghi O, Lumbroso J, Laplanche A, Bourhis J. Mamelle G, et al. Among authors: laplanche a. Cancer Radiother. 2006 Nov;10(6-7):349-53. doi: 10.1016/j.canrad.2006.06.011. Epub 2006 Aug 21. Cancer Radiother. 2006. PMID: 16919986 Clinical Trial. French.
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K, Faivre L, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, Ravaud A, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Martin AL, Habibian M, Laplanche A, Culine S. Fizazi K, et al. Among authors: laplanche a. Lancet Oncol. 2015 Jul;16(7):787-94. doi: 10.1016/S1470-2045(15)00011-X. Epub 2015 May 28. Lancet Oncol. 2015. PMID: 26028518 Clinical Trial.
Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
Loriot Y, Pagliaro L, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Laplanche A, Le Teuff G, Culine S, Fizazi K. Loriot Y, et al. Among authors: laplanche a. Eur J Cancer. 2017 Dec;87:140-146. doi: 10.1016/j.ejca.2017.09.029. Epub 2017 Nov 14. Eur J Cancer. 2017. PMID: 29149760 Clinical Trial.
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
Blanchard P, Faivre L, Lesaunier F, Salem N, Mesgouez-Nebout N, Deniau-Alexandre E, Rolland F, Ferrero JM, Houédé N, Mourey L, Théodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Davin JL, Habibian M, Culine S, Laplanche A, Fizazi K. Blanchard P, et al. Among authors: laplanche a. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):85-92. doi: 10.1016/j.ijrobp.2015.09.020. Epub 2015 Sep 25. Int J Radiat Oncol Biol Phys. 2016. PMID: 26576711 Clinical Trial.
176 results